Information Journal Paper
APA:
CopyDEHGHANIFARD, A.. (2013). EVALUATION OF NOVEL FETAL HEMOGLOBIN INDUCER DRUGS IN TREATMENT OF BETA-HEMOGLOBINOPATHY DISORDERS. INTERNATIONAL JOURNAL OF HEMATOLOGY-ONCOLOGY AND STEM CELL RESEARCH (IJHOSCR), 7(3), 47-54. SID. https://sid.ir/paper/313449/en
Vancouver:
CopyDEHGHANIFARD A.. EVALUATION OF NOVEL FETAL HEMOGLOBIN INDUCER DRUGS IN TREATMENT OF BETA-HEMOGLOBINOPATHY DISORDERS. INTERNATIONAL JOURNAL OF HEMATOLOGY-ONCOLOGY AND STEM CELL RESEARCH (IJHOSCR)[Internet]. 2013;7(3):47-54. Available from: https://sid.ir/paper/313449/en
IEEE:
CopyA. DEHGHANIFARD, “EVALUATION OF NOVEL FETAL HEMOGLOBIN INDUCER DRUGS IN TREATMENT OF BETA-HEMOGLOBINOPATHY DISORDERS,” INTERNATIONAL JOURNAL OF HEMATOLOGY-ONCOLOGY AND STEM CELL RESEARCH (IJHOSCR), vol. 7, no. 3, pp. 47–54, 2013, [Online]. Available: https://sid.ir/paper/313449/en